Dr. Vance Berger completed his PhD in statistics at Rutgers University in 1995, and then began working at the FDA. This is where he developed his research focus on biases and threats to the validity of medical studies, especially clinical trials. In 1999, Dr. Berger joined the NCI, and has remained ever since. In 2005, he published a book, "Selection Bias and Covariate Imbalances in Randomized Clinical Trials" (Wiley), and continues to work actively in the field of selection bias, allocation concealment, and randomization methods (as covered in this book), plus overall trial quality and robustness against unwarranted assumptions.
Back to top
DCP Home |
Contact DCP |
Viewing Files |
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®